Corrigendum to "In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways".
Erik SkoglundHenrietta AbodakpiRafael RiosLorena DiazElsa De La CadenaAn Q DinhJavier ArdilaWilliam R MillerJose M MunitaCesar A AriasVincent H TamTruc T TranPublished in: Case reports in infectious diseases (2019)
[This corrects the article DOI: 10.1155/2018/9095203.].